US7665596034 - Common Stock
RIGEL PHARMACEUTICALS INC
NASDAQ:RIGL (3/28/2024, 8:00:02 PM)
After market: 1.49 +0.01 (+0.68%)1.48
-0.01 (-0.67%)
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company is headquartered in South San Francisco, California and currently employs 155 full-time employees. The company went IPO on 2000-11-29. The firm is engaged in discovering, developing and providing therapies that improve the lives of patients with hematologic disorders and cancer. The firm's lead product, TAVALISSE (fostamatinib disodium hexahydrate) tablets, the spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia (ITP). Its product also includes REZLIDHIA (olutasidenib) capsules, which are for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. Its other clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program and a receptor-interacting serine/threonine-protein kinase (RIPK1) inhibitor program in clinical development. In addition, it has product candidates in clinical development with partners BerGenBio ASA (BerGenBio) and Daiichi Sankyo (Daiichi).
RIGEL PHARMACEUTICALS INC
611 Gateway Boulevard, Suite 900
South San Francisco CALIFORNIA 94080
P: 16506241100
CEO: Raul R. Rodriguez
Employees: 155
Website: https://www.rigel.com/
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the appointment of Lisa Rojkjaer, M.D. as Executive Vice President and Chief Medical...
RIGL stock results show that Rigel Pharmaceuticals beat on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rigel Pharmaceuticals (NASDAQ:RIGL) just reported results for the fourth quarte...
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and full year ended December 31, 2023,...
Here you can normally see the latest stock twits on RIGL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: